Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer  by Daddi, Giuliano et al.
Discussion
In patients with paraneoplastic SPS, surgical removal of the associ-
ating neoplasm is thought to be important in reducing neurologic
symptoms. Sommer and colleagues5 previously reported that rats
experienced spastic stiffness like human SPS with injection of puri-
fied IgG taken from a patient with paraneoplastic SPS associated with
breast cancer. This suggests that paraneoplastic production of auto-
antibodies could be associated with paraneoplastic SPS.
Clinically, Hagiwara and associates4 and Tanaka and cowork-
ers3 reported SPS cases in which the painful stiffness was reduced
by surgical resection of a thymoma. After resection, serum auto-
antibody titers should be reduced in such cases; however, in our
patient the GAD antibody titer was once again increased 2 weeks
after resection, despite a lack of symptoms. Moreover, as a result
of traumatic stimulation, SPS suddenly relapsed in the clinically
asymptomatic period after surgical intervention. This clinical
course suggests that surgical removal of the tumor does not always
mean the prevention of autoantibody productivity and is not al-
ways a curative treatment for paraneoplastic SPS, as with myas-
thenia gravis associated with thymoma.
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Limited information is currently available on the inci-dence of venous thromboembolism (VTE) in patientsundergoing lung surgery for cancer.1,2 Pulmonary em-bolism (PE) has been found to be a frequently fatal
postoperative complication, as confirmed by autopsy in 15.2% of
postresectional deaths.3 The clinical burden of PE in surgical
patients is underestimated, probably because the majority of VTE
remains asymptomatic or associated with aspecific symptoms.
Several factors increase the thromboembolic risk in patients un-
dergoing lung cancer surgery: intrinsic procoagulant effect of
cancer, extensive surgical intervention, dependent limb position in
the operating room, and vessel injury consequent to the operation.
PE in patients undergoing thoracic surgery has some peculiar-
ities. Indeed, in thoracic surgery, in addition to the established risk
factors for VTE, local factors related to surgical technique, direct
vascular injury, or both could play a remarkable role.4
The aim of this study was to assess the incidence of PE after
lung surgery for cancer by using multislice computed tomographic
(MSCT) scanning.
Methods
The Pulmonary Embolism in Thoracic Surgery Study was a pro-
spective study performed to identify the incidence of PE by means
of MSCT scanning after lung surgery for cancer.
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Figure 2. Pathologic findings of the resected thymoma. (Original
magnification 200.) Intracapsular invasion and both small lym-
phocytic and epithelial components were observed. The patient
was given a diagnosis of an invasive thymoma of mixed type.
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MSCT scanning was performed with a 4-row computed tomo-
gram (GE Light-Speed, 4  1.25); technical parameters were high
speed, 2.5-mm collimation, 220 mAs, and 120 Kv. All examina-
tions were separately reviewed by 2 different radiologists.
All patients underwent chest MSCT scanning within 7 to 15
days from the time of the operation. Diagnostic criteria for PE
were as follows: (1) abrupt cutoff of vessels, often distally en-
larged, in case of complete obstruction; (2) partial central vascular
filling defect (known as “polo mint” or “tram lining” signs); and
(3) partial eccentric vascular filling defect.
Patient data, including age, sex, history of VTE, previous major
operation, chemotherapy, comorbidity, smoking habit, medica-
tions, type of lung resection, tumor size, histology, and stage, were
considered potential risk factors for VTE.
Patients received pharmacologic prophylaxis for VTE with
low-molecular-weight heparin, starting 12 to 24 hours after surgi-
cal intervention until discharge, at a dosage of 3000 to 4000 UI/d.
The primary outcome of the study was PE incidence. The
secondary aim was to analyze the correlation between surgical
technique and the occurrence of thrombus in the pulmonary arte-
rial stumps. The study protocol was approved by the regional
institutional review board. All patients provided written informed
consent.
Results
Fifty patients were included in this study. The average age was
66.5 years (range, 26-90 years). Twelve were women, and 38 were
men. All but 2 patients received VTE prophylaxis.
Thirty-six patients underwent lobectomy, 12 underwent pneu-
monectomy, and 2 underwent wedge resection. The diagnosis of
cancer was confirmed in all cases except one, a patient affected by
tuberculosis.
Histology showed primary lung cancer in 47 patients. Details
are summarized in Table 1.
Among the patients with primary lung carcinoma, 18 were in
stage I, 14 were in stage II, and 15 were in stage III.
Seven (14%) patients showed PE at MSCT scanning, 5 involv-
ing the central arteries (principal, lobar, and segmentary) and 2
involving the subsegmentary arteries. Among the 7 positive cases,
2 were in situ thrombosis of the residual vascular stump, one with
direct extension to the contralateral pulmonary vasculature.
PE was bilateral in 2 patients. Two of the positive results at
MSCT scanning were symptomatic, and only 1 had a clinically
overt deep venous thrombosis confirmed by means of duplex
scanning. Because of low diagnostic accuracy, duplex scanning
was not performed in asymptomatic patients.
One patient died on postoperative day 10 of respiratory failure.
The results of MSCT scanning were negative for PE. Risk factors
for PE are summarized in Table 2.
Discussion
In this study the incidence of PE detected by means of MSCT
scanning after lung surgery for cancer was 14%, which is higher
than the 5% previously reported on the basis of lung scanning.1
As in other series on postoperative VTE, the majority of pa-
tients were asymptomatic. However, in our study population
symptoms caused by thoracotomy complicate the diagnosis of PE,
therefore contributing to the underestimation of its true incidence.
The clinical relevance of PE in patients undergoing thoracic sur-
gery for cancer remains undefined.
Early diagnosis of PE is essential to establish adequate treat-
ment to prevent recurrence.
PE in patients undergoing thoracic surgery for cancer has a
multifactorial origin. Injury at the operative site might play a
specific role. A long vascular stump might increase the risk of in
situ thrombosis.
Other potentially harmful technical aspects are as follows:
intimal dissection at the ligature sites, stenosis, and/or flow turbu-
lence induced by excessive angulations of the vascular axis.
In conclusion, we observed a high incidence of PE in patients
undergoing thoracic surgery for cancer despite prophylaxis. The
intrinsic mechanisms of these findings should be further explored.
Studies are required to identify the best prophylactic regimen in
such a clinical setting.
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Table 1. Cancer histology
Histology No. of patients
Epidermoid carcinoma 21 (42%)
Adenocarcinoma 14 (28%)
Anaplastic 4 (8%)
Benign 1 (2%)
Metastatic 2 (4%)
Other types 8 (16%)
Table 2. Risk factors for pulmonary embolism after lung
surgery
Risk factors Incidence
Male vs female sex 6/38 (15.7%) vs 1/12 (8.3%)
COPD vs no COPD 4/14 (28.6%) vs 3/36 (8.3%)
Lobectomy vs pneumonectomy 6/36 (16.6%) vs 1/12 (8.3%)
Lower lobectomy vs upper
lobectomy
4/16 (25.0%) vs 2/20 (10.0%)
Right side vs left side 3/20 (15%) vs 4/30 (13.3%)
Tumor 3 cm vs smaller tumors 5/37 (13.5%) vs 1/12 (8.3%)
COPD, Chronic obstructive pulmonary disease.
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